Literature DB >> 1340667

Wernicke's encephalopathy: occurrence and pathological aspects in a series of 400 AIDS patients.

R Boldorini1, L Vago, A Lechi, F Tedeschi, G R Trabattoni.   

Abstract

BACKGROUND: Wernicke encephalopathy (WE), acute (microhaemorrhages) and chronic (proliferation of capillaries) is actually considered as a not uncommon, and curable, condition in several diseases, and not only in alcoholic patients. Why serotoninergic nuclei, and whether blood brain barrier (BB) are involved were our questions.
METHODS: In a dramatic series of AIDS cases we selected 380 brains, all belonging to drug addicted subjects. In all Thiamine administration had been under 20 mg pro die and by oral way. In the cases considered, opportunistic infections were present in the 40%, and/or HIV specificity in the 35%.
RESULTS: "Acute" WE was found in nearly the 10%. All patients presented with CNS lesions, other than those of WE, but HIV specificity was found only in 5. They all showed changes in Choroid Plexus, namely alterations of various type of the cuboid epithelium, such as swelling, disruption, hyperplasia. DISCUSSION: WE is set in connection with pyruvate accumulation at capillary level, likely bound to the Thiamine deficiency and to the lack of energy thus induced. Apart from obvious haemorrhagic aspects, CFS studies in WE are lacking. Choroid structure is not merely a permeable membrane (CSF is not a filtrate). Our findings would suggest that Thiamine plays a role in the energy supply to BB. Moreover, the existence of free nerve endings through the ependyma for the release and uptake of monoamines, allows to consider the elective involvement of serotoninergic neurons as somehow connected to the choroid plexus changes described.

Entities:  

Mesh:

Year:  1992        PMID: 1340667

Source DB:  PubMed          Journal:  Acta Biomed Ateneo Parmense


  7 in total

Review 1.  Palliative treatment of thiamine-related encephalopathy (Wernicke's encephalopathy) in cancer: A case series and review of the literature.

Authors:  Elie Isenberg-Grzeda; Alan John Hsu; Vaios Hatzoglou; Christian Nelso; William Breitbart
Journal:  Palliat Support Care       Date:  2014-10-23

2.  Clinical Characteristics and Outcomes Associated With High-Dose Intravenous Thiamine Administration in Patients With Encephalopathy.

Authors:  Zev M Nakamura; Jason R Tatreau; Donald L Rosenstein; Eliza M Park
Journal:  Psychosomatics       Date:  2018-01-11       Impact factor: 2.386

Review 3.  Molecular and neurologic responses to chronic alcohol use.

Authors:  B N Costin; M F Miles
Journal:  Handb Clin Neurol       Date:  2014

Review 4.  Wernicke's encephalopathy: expanding the diagnostic toolbox.

Authors:  Mary E Lough
Journal:  Neuropsychol Rev       Date:  2012-05-11       Impact factor: 7.444

5.  Wernicke's Encephalopathy in a Patient Without Chronic Alcohol Abuse.

Authors:  Darshan Thota; Sherri Rudinsky
Journal:  Clin Pract Cases Emerg Med       Date:  2017-03-14

6.  Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile.

Authors:  Vatsalya Vatsalya; Fengyuan Li; Jane Frimodig; Khushboo S Gala; Shweta Srivastava; Maiying Kong; Vijay A Ramchandani; Wenke Feng; Xiang Zhang; Craig J McClain
Journal:  Front Pharmacol       Date:  2021-03-02       Impact factor: 5.810

7.  Wernicke's Encephalopathy: An Unusual Consequence of the Acquired Immune Deficiency Syndrome-Case Report and Literature Review.

Authors:  Timothy R Larsen; Dritan Dragu; Michael Williams
Journal:  Case Rep Med       Date:  2013-07-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.